Sartorius Expertise for Pharmaceutical Degree

Article

Dr. Uwe Gottschalk, vice president of purification technologies at Sartorius AG (Goettingen, Germany, www.sartorious.com) and member of BioPharm International's editorial advisory board, will now also be a lecturer at the University of Duisburg-Essen, for the first Master's degree program in pharmaceutical medicine.

Dr. Uwe Gottschalk, vice president of purification technologies at Sartorius AG (Goettingen, Germany, www.sartorious.com) and a member of BioPharm International’s editorial advisory board, will now also be a lecturer at the University of Duisburg-Essen, for the first Master’s degree program in pharmaceutical medicine. This internationally focused program is accredited throughout Germany and is designed to qualify medical and scientific students for managerial positions in research, development, approvals, and marketing of pharmaceuticals and medical products. Based in Goettingen, Germany, Dr. Gottschalk will manage the biotechnology study module and lecture on the development and production aspects of biopharmaceutical products.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Mike Schaefers Simtra BioPharma Solutions, Shiva Khalafpour MilliporeSigma, the Life Science Business of Merck KGaA, Darmstadt, Germany
Chris Hagan, SCIEX
Daniel Fischer, Tevard
Junevity Co-founder & CEO, John Hoekman, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.